The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm, Multi-Center, Prospective Study.
Texto
Documentos relacionados
Efficacy and safety of amrubicin for the elderly patients with refractory relapsed small cell lung cancer as third-line chemotherapy. Further investigations
To analyze and describe a series of patients with non- small cell lung cancer treated with erlotinib during a period prior to the mandatory investigation of the epidermal
However, in a recent retrospective study that evaluated the accuracy of multi-slice chest CTs in mediastinum nodal staging in 86 patients with non-small cell lung cancer,
Survival and prognostic factors in patients with Non-Small Cell Lung Cancer treated in private health care.. Sobrevida e fatores prognósticos em pacientes com câncer de pulmão de
The objective of the present study was to analyze the effect of chemotherapy on the physical condition of patients with advanced non-small cell lung cancer
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern
Clinical outcomes and prognostic factors of patients with advanced non-small cell lung treated in clinical trials in Brazil: A single institution experience. Leite GM, França
The objective of the present study was to analyze the effect of chemotherapy on the physical condition of patients with advanced non-small cell lung cancer
